ArtiQ
Leuven
About ArtiQ
ArtiQ is a young, dynamic and innovative spin-off company of the University of Leuven (Belgium). Company is founded in early 2019 by four committed founders with a long history in respiratory medicine, medical devices and artificial intelligence. Working on a junction of multidisciplinary fields, founders identified opportunity and value that novel technologies could bring to all parties in a respiratory setting: patients, doctors, healthcare system and industry. ArtiQ aims to become the trusted partner of medical practitioners for the diagnosis, treatment, and follow-up of respiratory problems. With the first developed artificial intelligence-based medical software, ArtiQ is already helping interpretation of pulmonary function tests and improving lung disease diagnostic environment.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $1.1M
- Funding stage: M&A
- Last round: Seed (Jul 2019)
- Website: artiq.eu
- Phone: info@artiq.eu
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Health Care, Information Technology, Software
Social Profiles
Canonical: https://fsome.com/organization/artiq-25 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.